CA2288693A1 - Procede d'amelioration de comportements perturbes et de stimulation de l'humeur chez des humains - Google Patents
Procede d'amelioration de comportements perturbes et de stimulation de l'humeur chez des humains Download PDFInfo
- Publication number
- CA2288693A1 CA2288693A1 CA002288693A CA2288693A CA2288693A1 CA 2288693 A1 CA2288693 A1 CA 2288693A1 CA 002288693 A CA002288693 A CA 002288693A CA 2288693 A CA2288693 A CA 2288693A CA 2288693 A1 CA2288693 A1 CA 2288693A1
- Authority
- CA
- Canada
- Prior art keywords
- dronabinol
- patients
- dementia
- administered
- humans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Cette invention se rapporte à un procédé d'amélioration des comportements perturbés et de stimulation de la bonne humeur chez des sujets atteints de démence, notamment chez des humains atteints de démence telle que celle liée à la maladie d'Alzheimer, ledit procédé consistant en l'administration de dronabinol.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4581397P | 1997-05-07 | 1997-05-07 | |
US60/045,813 | 1997-05-07 | ||
US08/866,511 | 1997-05-30 | ||
US08/866,511 US5804592A (en) | 1997-05-30 | 1997-05-30 | Method for improving disturbed behavior and elevating mood in humans |
PCT/US1998/009269 WO1998050027A1 (fr) | 1997-05-07 | 1998-05-06 | Procede d'amelioration de comportements perturbes et de stimulation de l'humeur chez des humains |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2288693A1 true CA2288693A1 (fr) | 1998-11-12 |
Family
ID=26723227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002288693A Abandoned CA2288693A1 (fr) | 1997-05-07 | 1998-05-06 | Procede d'amelioration de comportements perturbes et de stimulation de l'humeur chez des humains |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1019041A4 (fr) |
JP (1) | JP2002501510A (fr) |
AU (1) | AU743788B2 (fr) |
CA (1) | CA2288693A1 (fr) |
IL (1) | IL132784A (fr) |
WO (1) | WO1998050027A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
EP3955918A1 (fr) | 2019-04-17 | 2022-02-23 | COMPASS Pathfinder Limited | Procédés pour traiter les troubles neurocognitifs, la douleur chronique, et pour réduire l'inflammation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5521215A (en) * | 1989-11-07 | 1996-05-28 | Ramot University Authority For Applied Research And Industrial Development Ltd. | NMDA-blocking pharmaceuticals |
IL92238A (en) * | 1989-11-07 | 1995-07-31 | Yissum Res Dev Co | ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation |
US5596106A (en) * | 1994-07-15 | 1997-01-21 | Eli Lilly And Company | Cannabinoid receptor antagonists |
-
1998
- 1998-05-06 AU AU72916/98A patent/AU743788B2/en not_active Ceased
- 1998-05-06 JP JP54846498A patent/JP2002501510A/ja not_active Ceased
- 1998-05-06 CA CA002288693A patent/CA2288693A1/fr not_active Abandoned
- 1998-05-06 IL IL13278498A patent/IL132784A/en not_active IP Right Cessation
- 1998-05-06 EP EP98920311A patent/EP1019041A4/fr not_active Withdrawn
- 1998-05-06 WO PCT/US1998/009269 patent/WO1998050027A1/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2002501510A (ja) | 2002-01-15 |
AU743788B2 (en) | 2002-02-07 |
WO1998050027A1 (fr) | 1998-11-12 |
EP1019041A4 (fr) | 2002-04-17 |
IL132784A (en) | 2004-07-25 |
AU7291698A (en) | 1998-11-27 |
IL132784A0 (en) | 2001-03-19 |
EP1019041A1 (fr) | 2000-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5804592A (en) | Method for improving disturbed behavior and elevating mood in humans | |
Volicer et al. | Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease | |
Campbell et al. | Naltrexone in autistic children: behavioral symptoms and attentional learning | |
Lockman et al. | Relief of pain of Fabry's disease by diphenylhydantoin | |
RU2281771C2 (ru) | Использование декстрометорфана и ингибитора оксидазы для отучения пациентов от наркотиков и антидепрессантов | |
Moretti et al. | Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: a 24-month follow-up of 68 patients | |
Robinson et al. | Sodium oxybate: a review of its use in the management of narcolepsy | |
US20060252761A1 (en) | Augmentation of extinction via administration of sub-antimicrobial doses of D-cycloserine | |
EP2214683B1 (fr) | Dosage unitaire pour la sante cerebrale | |
TW201900158A (zh) | 使用氟苯丙胺治療杜希氏徵候群之方法 | |
US20100178362A1 (en) | Chromium complexes for improvement of memory and cognitive function | |
MX2012001814A (es) | Uso de 4-aminopiridina para mejorar la discapacidad neuro - cognoscitiva y/o neuro - psiquiatrica en pacientes con condiciones desmielizantes y otras condiciones del sistema nervioso. | |
KR100530879B1 (ko) | 알카노일 카르니틴 유도체를 함유한 주의력-결핍 및 과잉행동 장애 치료용 약제조성물 | |
EP2163244B1 (fr) | Utilisation de polyprénols pour la préparation d'une composition pharmaceutique pour le traitement de la dépendance à l'alcool éthylique et/ou aux drogues | |
AU743788B2 (en) | Method of improving disturbed behavior and elevating mood in humans | |
MXPA99010187A (en) | Method of improving disturbed behavior and elevating mood in humans | |
US5863925A (en) | Use of sulbutiamine in the treatment of Parkinson's disease, schizophrenia, alcoholism, and dysthymia | |
Lask | Treatment of Vomiting of Pregnancy with Antihistamines | |
AU749169B2 (en) | A method for preventing the onset of asthma | |
Adams | The Gordon Wilson Lecture. Nutritional Diseases of the Nervous System in the Alcoholic Patient | |
Shua-Haim et al. | Donepezil (AriceptTM): The caregivers voice and clinical impression | |
DeJONG | Vitamin E and alpha tocopherol therapy of neuromuscular and muscular disorders | |
Safer | Drug treatment in child psychiatry | |
WO1996021446A1 (fr) | Composition pharmaceutique a proprietes antialcooliques et nootropes | |
CA1118352A (fr) | Procede de preparation de nouvelles compositions pharmaceutiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |
Effective date: 20150506 |